Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies.

Lanoue J, Goldenberg G.

J Clin Aesthet Dermatol. 2016 May;9(5):26-36. Epub 2016 May 1. Review.

2.

Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.

de Macedo EM, Carneiro RC, de Lima PP, Silva BG, Matayoshi S.

BMC Ophthalmol. 2015 Apr 3;15:35. doi: 10.1186/s12886-015-0024-0.

3.

Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.

Vacchelli E, Galluzzi L, Eggermont A, Fridman WH, Galon J, Saut├Ęs-Fridman C, Tartour E, Zitvogel L, Kroemer G.

Oncoimmunology. 2012 Sep 1;1(6):894-907.

4.

Treatment of facial Basal cell carcinoma: a review.

Smith V, Walton S.

J Skin Cancer. 2011;2011:380371. doi: 10.1155/2011/380371. Epub 2011 Apr 27.

5.

Periungual Basal cell carcinoma: a case report with review of literature.

Bandyopadhyay D, Sen S.

Indian J Dermatol. 2011 Mar;56(2):220-2. doi: 10.4103/0019-5154.80425.

6.

Treatment of Basal cell carcinoma with curettage followed by imiquimod 3.75% cream.

Zeichner JA, Patel RV, Birge MB.

J Clin Aesthet Dermatol. 2011 May;4(5):39-43.

7.

Nonsurgical innovations in the treatment of nonmelanoma skin cancer.

Amini S, Viera MH, Valins W, Berman B.

J Clin Aesthet Dermatol. 2010 Jun;3(6):20-34.

8.

Treatment of cutaneous tumors with topical 5% imiquimod cream.

Alessi SS, Sanches JA, Oliveira WR, Messina MC, Pimentel ER, Festa Neto C.

Clinics (Sao Paulo). 2009;64(10):961-6. doi: 10.1590/S1807-59322009001000005.

9.

Advances in the use of topical imiquimod to treat dermatologic disorders.

Lacarrubba F, Nasca MR, Micali G.

Ther Clin Risk Manag. 2008 Feb;4(1):87-97.

10.

Interventions for basal cell carcinoma of the skin: systematic review.

Bath-Hextall F, Bong J, Perkins W, Williams H.

BMJ. 2004 Sep 25;329(7468):705. Epub 2004 Sep 13. Review.

Supplemental Content

Support Center